3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
5
Recurrence
3
Neoplasm Metastasis
3
Melanoma
3
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Cutaneous Squamous Cell Carcinoma
2
Carcinoma, Basal Cell
2
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Ovarian Neoplasms
1
Neoplasms
1
Multiple Myeloma
1
Lymphoma
1
Head and Neck Neoplasms
1
Glioma
1
Glioblastoma
1
Diffuse Intrinsic Pontine Glioma
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Central Nervous System Neoplasms
1
Carcinoma, Squamous Cell
1
Carcinoma, Merkel Cell
1
Breast Neoplasms
1
Advanced Non-Small Cell Lung Carcinoma
1
Adenocarcinoma
1
Interventions
Mitotane
4
Cisplatin
3
pembrolizumab
2
cixutumumab
2
Etoposide
2
Doxorubicin
2
Dichlorodiphenyldichloroethane
2
sodium thiosulfate
1
relacorilant
1
pegfilgrastim
1
milademetan
1
gossypol acetic acid
1
cabozantinib
1
avelumab
1
antineoplaston AS 2-1
1
antineoplaston A10
1
Sunitinib
1
Streptozocin
1
Platinum
1
Nivolumab
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Fentanyl
1
Ethane
1
Cytoreduction Surgical Procedures
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Adrenocortical Carcinoma
×
cemiplimab
×
Clear all
No trials found.